Post

New research · Ophthalmology
Ophthalmic surgery, lasers & imaging retina · 2d
Cross-sectionalOphthalmic surgery, lasers & imaging retina · 2026

Trends in the Initial Treatment for Retinopathy of Prematurity in the United States.

Charles Zhang, Sinan Ersan, Joaquin A Sosa-Lockward … Audina M Berrocal
Read paper
OphthalmologyCross-sectional

Laser therapy remains the most common initial treatment for retinopathy of prematurity in the US

Trends in the Initial Treatment for Retinopathy of Prematurity in the United States.

Charles Zhang … Audina M Berrocal
Ophthalmic surgery, lasers & imaging retina · 2026
Background

The aim of this study was to characterize trends in choice of initial therapy for retinopathy of prematurity (retinopathy of prematurity) in the United States.

Methods

This is a cross-sectional time-series analysis on infants diagnosed with retinopathy of prematurity categorized by initial treatment modality (laser photocoagulation/cryotherapy or intravitreal injection).

n = 2,050 infants
Results

laser stayed the go-to treatment even as newer eye injections became more common

100%
Before
62.7%
After
More results

A total of 2,050 infants met inclusion criteria.

Bevacizumab decreased from 100% of all intravitreal injections to 76.7% ( P < .0001).

Aflibercept use increased from 0% to 18.8% ( P < .0001).

More results

White infants were more likely to be treated with intravitreal anti-VEGF than Black or Hispanic infants ( P = .0061).

“
Conclusion

The rates of anti-VEGF for initial treatment have been rising over the years; however, laser photocoagulation remains the most common treatment for retinopathy of prematurity in the United States.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
AI / Informatics
0·962 for OCT
MerMED-FM was very accurate at diagnosing diseases using eye scans
AI / Informatics
0.98
Artificial intelligence's eyelid-height measurements matched doctors' manual measurements almost perfectly
AI / Informatics
92.1%
combining eye scans and photos correctly told benign from cancerous lesions apart nearly every time
Cohort Study
28.6%
recurred locally in more than 1 in 4 patients over years of follow-up
Cohort Study
-0.395
excision group's post-op eyelid fullness score was lower - greater improvement
Cohort Study
86.7%
of infants probed after 12 months still had unresolved tear duct blockage
Observational
16%
eyelid tissue in rosacea patients showed less of this key repair-signaling protein inside cell nuclei
Cohort Study
25%
about 1 in 4 treated cases had symptoms return after improving